GENERIC DRUGS IN COVID-19 TREATMENT

Ujban Md. Hussain Hussain (B.Pharm)* and Samiksha Sandeep Tammewar (B.Pharm)

ABSTRACT

Coronavirus disease-2019 (COVID-19) is a disease-causing virus, which is brought on by SARS-CoV-2 diseases. The disease is characterized by a large number of virulence-related infections, including hepatitis B and C infections, chikungunya infection, reovirus, Hantaan infection, and coxsackie virus B5.13. In addition, a variety of antiviral medicines have been proposed as a potential treatment and preventative medicine for the disease. In this audit, we go over the accessible evidence for and against hydroxychloroquine's use as prophylaxis or treatment for COVID19, particularly within the Indian context. In the present review, we focus on the pharmacopeia for safe generic medications that target the pathophysiology's causing the disease in order to guarantee that patients with the disease have quick access to safe treatments and to ensure the responsible use of available resources.

Keywords: .